SCHEMBL4427728

SCHEMBL4427728

CCCCOCCOc1ccc(/C=C2\CC(=O)OC2=O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
KDM4E B2RXH2 2/20 0.43
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
RARB P10826 1/20 0.42
PIM1 P11309 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
MAOB P27338 8/20 0.41
MAOA P21397 6/20 0.41
NPC1 O15118 1/20 0.41
CASP3 P42574 1/20 0.41
RAB9A P51151 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
BCHE P06276 4/20 0.41
ACHE P22303 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4401889 0.89 MAPT (0.53) MAPTKDM4EPOLBL3MBTL1MEN1
SCHEMBL4400352 0.82 MAOB (0.41) MAPTKDM4EPOLBL3MBTL1PIM1
SCHEMBL9049778 0.76 DYRK1A (0.59) MAPTKDM4EPOLBKMT2ASMN1; SMN2
SCHEMBL9049784 0.76 DYRK1A (0.59) MAPTKDM4EPOLBKMT2ASMN1; SMN2
SCHEMBL11159952 0.73 DYRK1A (0.68) MAPTKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL3681798 0.72 ALDH1A1 (0.63) MAPTMEN1KMT2ASMN1; SMN2RARB
SCHEMBL4138972 0.72 MAPT (0.53) MAPTKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL13902581 0.72 MAPT (0.53) MAPTKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL4138976 0.72 MAPT (0.53) MAPTKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL10629620 0.72 RARB (0.64) KDM4EL3MBTL1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120107239-A1 Precursor of Molecular Probe for Pancreatic Islet Imaging and Use of the Same ARKRAY, INC. (JP) 2012-05-03 US disclosed
EP-2407455-A1 MOLECULAR PROBE PRECURSOR FOR PANCREATIC ISLET IMAGING AND USE OF SAME Kyoto University (JP) 2012-01-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120107239-A1 Precursor of Molecular Probe for Pancreatic Islet Imaging and Use of the Same OGFRL1, OXSR1, IAPP MAPT 4813/4885KDM4E 4799/4885POLB 2873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.